Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients

Strahlentherapie und Onkologie

Volumn 187, Issue 12, 2011, Pages 784-791

  Langsenlehner, Tanja ^a   Renner, Wilfried ^a   Gerger, Armin ^a   Hofmann, Günter ^a   Thurner, Eva Maria ^a   Kapp, Karin S ^a   Langsenlehner, Uwe ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Division of Internal Medicine   (Austria)

Author keywords

Haplotypes; Late toxicity; Predictive factors; Radiotherapy; VEGF polymorphisms

Indexed keywords

5' NUCLEOTIDASE; VASCULOTROPIN;

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CONFOUNDING VARIABLE; DNA POLYMORPHISM; DOSIMETRY; FOLLOW UP; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOTE; HUMAN; PREDICTOR VARIABLE; PROSTATE CANCER; RADIATION INJURY; RECTUM DISEASE; UROGENITAL TRACT DISEASE;

AGED; ALLELES; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HETEROZYGOTE DETECTION; HUMANS; KAPLAN-MEIER ESTIMATE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIATION INJURIES; RECTUM; URINARY BLADDER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856190041     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-1106-4     Document Type: Article

References (51)

1. S. Abhary K.P. Burdon A. Gupta 2009 Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy Invest Ophthalmol Vis Sci 50 5552 8 19553626 10.1167/iovs.09-3694
2. C.N. Andreassen J. Alsner M. Overgaard 2003 Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes Radiother Oncol 69 127 35 14643949 10.1016/j.radonc.2003.09.010 1:CAS:528:DC%2BD3sXpt1Wgsr0%3D (Pubitemid 37485871)
3. M.S. Anscher L. Chen Z. Rabbani 2005 Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy Int J Radiat Oncol Biol Phys 62 255 9 15850930 10.1016/j.ijrobp.2005.01.040 (Pubitemid 40591951)
4. M.S. Anscher Z. Vujaskovic 2005 Mechanisms and potential targets for prevention and treatment of normal tissue injury after radiation therapy Semin Oncol 32 86 91 10.1053/j.seminoncol.2005.03.015
5. D. Azria M. Ozsahin A. Kramar 2008 Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy Clin Cancer Res 14 6284 8 18829510 10.1158/1078-0432.CCR-08-0700 1:CAS:528:DC%2BD1cXhtF2nurnP
6. M.H. Barcellos-Hoff C. Park E.G. Wright 2005 Radiation and the microenvironment - tumorigenesis and therapy Nat Rev Cancer 5 867 75 16327765 10.1038/nrc1735 1:CAS:528:DC%2BD2MXht1Witb7O (Pubitemid 41746031)
7. D. Beddy R.W. Watson J.M. Fitzpatrick 2004 Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease Br J Surg 91 72 7 14716797 10.1002/bjs.4453 1:CAS:528:DC%2BD2cXltVWru78%3D (Pubitemid 38122053)
8. W.B. Breunis M.H. Biezeveld J. Geissler 2006 Vascular endothelial growth factor gene haplotypes in Kawasaki disease Arthritis Rheum 54 1588 94 16645995 10.1002/art.21811 1:CAS:528:DC%2BD28XlsFWjsr0%3D
9. R.J. Burri R.G. Stock J.A. Cesaretti 2008 Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer Radiat Res 170 49 59 18582155 10.1667/RR1219.1 1:CAS:528:DC%2BD1cXotlKksLY%3D (Pubitemid 351931187)
10. J.A. Cesaretti R.G. Stock D.P. Atencio 2007 A genetically determined dose volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy Int J Radiat Oncol Biol Phys 68 1410 6 17490827 10.1016/j.ijrobp.2007.02.052 (Pubitemid 47176801)
11. J. Chang-Claude C.B. Ambrosone C. Lilla 2009 Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer Br J Cancer 100 1680 6 19367277 10.1038/sj.bjc.6605036 1:CAS:528:DC%2BD1MXlslChtLg%3D
12. V. Chintalgattu D.M. Nair L.C. Katwa 2003 Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR J Mol Cell Cardiol 35 277 86 12676542 10.1016/S0022-2828(03)00006-3 1:CAS:528:DC%2BD3sXisFWmtLw%3D (Pubitemid 36379171)
13. J.D. Cox J. Stetz T.F. Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1341 6 7713792 10.1016/0360-3016(95)00060-C 1:STN:280:DyaK2M3ivFCrsA%3D%3D
14. S. Damaraju D. Murray J. Dufour 2006 Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer Clin Cancer Res 12 2545 54 16638864 10.1158/1078-0432.CCR-05-2703 1:CAS:528:DC%2BD28XjvValu7s%3D
15. K. De Ruyck M. Van Eijkeren K. Claes 2005 Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes Int J Radiat Oncol Biol Phys 62 1140 9 15990020 10.1016/j.ijrobp.2004.12.027 (Pubitemid 40884429)
16. H.F. Dvorak 2002 Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 4368 80 12409337 10.1200/JCO.2002.10.088 1:CAS:528:DC%2BD38Xpt1CjtL0%3D (Pubitemid 35266299)
17. H.F. Dvorak L.F. Brown M. Detmar 1995 Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 1029 39 7538264 1:CAS:528:DyaK2MXmt1Kkt7g%3D
18. N. Ferrara H.P. Gerber J. LeCouter 2003 The biology of VEGF and its receptors Nat Med 9 669 676 12778165 10.1038/nm0603-669 1:CAS:528: DC%2BD3sXktFOnur4%3D (Pubitemid 36749215)
19. M. García-Closas N. Malats F.X. Real 2007 Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk PLoS Genet 3 e29 17319747 10.1371/journal.pgen.0030029
20. G. Giotopoulos R.P. Symonds K. Foweraker 2007 The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes Br J Cancer 96 1001 7 17325707 10.1038/sj.bjc.6603637 1:CAS:528:DC%2BD2sXjt1Srs7Y%3D (Pubitemid 46452279)
21. M. Guckenberger S. Ok B. Polat 2010 Toxicity after Intensity modulated, image-guided radiotherapy for prostate cancer Strahlenther Onkol 186 535 43 20890743 10.1007/s00066-010-2144-z
22. J. Hermesse S. Biver N. Jansen 2009 A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy Strahlenther Onkol 185 736 42 19899007 10.1007/s00066-009- 2009-5
23. D.J. Hicklin L.M. Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 1011 27 15585754 10.1200/JCO.2005.06.081 1:CAS:528:DC%2BD2MXit1Gnsro%3D (Pubitemid 46202320)
24. J. Jaal W. Dörr 2006 Radiation induced late damage to the barrier function of small blood vessels in mouse bladder J Urol 176 2696 700 17085198 10.1016/j.juro.2006.07.138 (Pubitemid 44665971)
25. V. Jacob W. Bayer S.T. Astner 2010 A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors Strahlenther Onkol 186 502 10 20803184 10.1007/s00066-010-2124-3
26. L. Jain C.A. Vargo R. Danesi 2009 The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors Mol Cancer Ther 8 2496 508 19755511 10.1158/1535-7163.MCT-09-0302 1:CAS:528:DC%2BD1MXhtFCis7rO
27. S.L. Kerns H. Ostrer R. Stock 2010 Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 78 1292 300 20932654 10.1016/j.ijrobp.2010. 07.036 1:CAS:528:DC%2BC3cXhsVGntLfL
28. T. Kobayashi X. Liu F.Q. Wen 2006 Smad3 mediates TGFbeta 1 induction of VEGF production in lung fibroblasts Biochem Biophys Res Commun 339 290 5 16298342 10.1016/j.bbrc.2005.10.209 1:CAS:528:DC%2BD2MXht1OrsbfK (Pubitemid 41697548)
29. T. Langsenlehner U. Langsenlehner W. Renner 2008 The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases Prostate 68 264 8 18163425 10.1002/pros.20682 1:CAS:528:DC%2BD1cXjtFemurw%3D (Pubitemid 351273055)
30. U. Langsenlehner P. Krippl W. Renner 2005 Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk Breast Cancer Res Treat 90 113 5 15803357 10.1007/s10549-004-3607-7 1:CAS:528:DC%2BD2MXivVKhs74%3D (Pubitemid 40568894)
31. A.K. Liu M.E. Macy N.K. Foreman 2009 Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas Int J Radiat Oncol Biol Phys 75 1148 54 19857784 10.1016/j.ijrobp.2008.12.070 1:CAS:528:DC%2BD1MXhtlWitL%2FF
32. Y. Liu K. Kudo Y. Abe 2008 Hypoxia expression in radiation-induced late rectal injury J Radiat Res 49 261 8 18296870 10.1269/jrr.07099 1:CAS:528:DC%2BD1cXhtVWnur7I (Pubitemid 351744278)
33. Y. Liu K. Kudo Y. Abe 2009 Inhibition of transforming growth factor beta, hypoxia- inducible factor-1alpha and vascular endothelial growth factor reduced late rectal injury induced by irradiation J Radiat Res 50 233 9 19346676 10.1269/jrr.08112 1:CAS:528:DC%2BD1MXnvVOnsrg%3D
34. C. Matuschek E. Bölke J. Nawatny 2011 Bevacizumab as a Treatment Option for Radiation Induced Cerebral Necrosis Strahlenther Onkol 187 135 9 21336713 10.1007/s00066-010-2184-4
35. A. Minchenko S. Salceda T. Bauer 1994 Hypoxia regulatory elements of the human vascular endothelial growth factor gene Cell Mol Biol Res 40 35 9 7528597 1:CAS:528:DyaK2cXmslart7s%3D (Pubitemid 24292725)
36. R.A. Nordal A. Nagy M. Pintilie 2004 Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor Clin Cancer Res 10 3342 53 15161688 10.1158/1078-0432.CCR-03-0426 1:CAS:528:DC%2BD2cXkt1GhsL4%3D (Pubitemid 38685439)
37. C.A. Peters R.G. Stock J.A. Cesaretti 2008 TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy Int J Radiat Oncol Biol Phys 70 752 9 17689884 10.1016/j.ijrobp.2007.05.023 1:CAS:528:DC%2BD1cXhsl2hu7k%3D (Pubitemid 351199705)
38. S. Quarmby H. Fakhoury E. Levine 2003 Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients Int J Radiat Biol 79 137 43 12569017 1:CAS:528:DC%2BD3sXoslOjsA%3D%3D (Pubitemid 36183072)
39. Z.N. Rabbani J. Mi Y. Zhang 2010 Hypoxia inducible factor 1alpha signaling in fractionated radiation-induced lung injury: role of oxidative stress and tissue hypoxia Radiat Res 173 165 74 20095848 10.1667/RR1816.1 1:CAS:528:DC%2BC3cXhslaltbc%3D
40. H.P. Rodemann M.A. Blaese 2007 Responses of normal cells to ionizing radiation Semin Radiat Oncol 17 81 8 17395038 10.1016/j.semradonc.2006.11.005 (Pubitemid 46467380)
41. E.K. Rofstad J.V. Gaustad T.A. Egeland 2010 Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination Int J Cancer 127 1535 46 20091868 10.1002/ijc.25176 1:CAS:528:DC%2BC3cXpvV2itb0%3D
42. A. Schultz L. Lavie I. Hochberg 1999 Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation Circulation 100 547 52 10430770 1:STN:280:DyaK1MzlvFyrsw%3D%3D (Pubitemid 29360165)
43. M. Stephens N.J. Smith P. Donnelly 2001 A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 978 89 11254454 10.1086/319501 1:STN:280:DC%2BD3M3kslWgsA%3D%3D (Pubitemid 32289743)
44. R. Torcuator R. Zuniga Y.S. Mohan 2009 Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis J Neurooncol 94 63 8 19189055 10.1007/s11060-009-9801-z 1:CAS:528: DC%2BD1MXotFWhs7k%3D
45. P.G. Tsoutsou M.I. Koukourakis 2006 Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research Int J Radiat Oncol Biol Phys 66 1281 93 17126203 10.1016/j.ijrobp.2006.08.058
46. Z. Vujaskovic M.S. Anscher Q.F. Feng 2001 Radiation-induced hypoxia may perpetuate late normal tissue injury Int J Radiat Oncol Biol Phys 50 851 5 11429211 10.1016/S0360-3016(01)01593-0 1:STN:280:DC%2BD3Mznt1KmtQ%3D%3D (Pubitemid 32594826)
47. J. Werbrouck K. De Ruyck F. Duprez 2009 Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes Int J Radiat Oncol Biol Phys 73 1187 95 19251090 10.1016/j.ijrobp.2008.08.073 1:CAS:528:DC%2BD1MXisVOgsbg%3D
48. D. Wolff F. Stieler B. Hermann 2010 Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++ Strahlenther Onkol 186 280 8 20437018 10.1007/s00066-010-2071-z
49. M. Yamamori T. Sakaeda T. Nakamura 2004 Association of VEGF genotype with mRNA level in colorectal adenocarcinomas Biochem Biophys Res Commun 325 144 50 15522212 10.1016/j.bbrc.2004.10.005 1:CAS:528:DC%2BD2cXpt1artLk%3D (Pubitemid 39441172)
50. H. Yoshiji S. Kuriyama J. Yoshii 2003 Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut 52 1347 54 12912869 10.1136/gut.52.9.1347 1:CAS:528:DC%2BD3sXnsFCgtLs%3D (Pubitemid 37026470)
51. X. Yuan Z. Liao Z. Liu 2009 Single Nucleotide Polymorphism at rs1982073:T869C of the TGFb1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy J Clin Oncol 27 3370 8 19380441 10.1200/JCO.2008.20.6763 1:CAS:528:DC%2BD1MXpvFejt7Y%3D